What Survives When Ketanserin Blocks a Psilocybin Trip
Content warning: discusses psychedelic drug pharmacology
A pharmacology deep dive into which effects of psilocybin persist under 5-HT2A blockade, moving from mechanism to the actual human trial data.
Related
Mapping Ibrutinib's Gene Interactions and Resistance Variants
A biomedical database walkthrough tracing which genes interact with the leukemia drug Ibrutinib, and which of their variants predict resistance or response.
Which cancer drugs work best against EGFR-amplified tumors
A rapid-fire database query pulls together every FDA-approved EGFR inhibitor and the clinical trial evidence for which cancers actually respond to them.
A 2024-2025 tour of migraine drug research
A digest of 2024-2025 migraine drug research spanning CGRP therapies, a dual-target compound, nerve blocks, gut microbiota links, and placebo response rates.
A Curated Reading List on Exercise and Cancer Treatment
A collection of reviews, meta-analyses, and trials on how exercise affects cancer risk, treatment side effects, and recovery outcomes across cancer types.